The influence of percutaneous atrial septal defect closure on the occurrence of migraine

European Heart Journal

Volumn 26, Issue 15, 2005, Pages 1533-1537

  Mortelmans, Katrin ^a   Post, Martijn ^a   Thijs, Vincent ^a   Herroelen, Luc ^a   Budts, Werner ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

Amplatzer device; Atrial septum defect; Migraine; Transcatheter closure

Indexed keywords

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DATA BASE; DEVICE; FEMALE; FOLLOW UP; HEADACHE; HEART ATRIUM SEPTUM DEFECT; HEART SURGERY; HUMAN; MAJOR CLINICAL STUDY; MALE; MIGRAINE; MIGRAINE AURA; ONSET AGE; PREVALENCE; PRIORITY JOURNAL; QUESTIONNAIRE; STATISTICAL ANALYSIS;

ADOLESCENT; ADULT; AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; BALLOON OCCLUSION; FEMALE; FOLLOW-UP STUDIES; HEART SEPTAL DEFECTS, ATRIAL; HEMODYNAMIC PROCESSES; HUMANS; MALE; MIDDLE AGED; MIGRAINE DISORDERS; QUESTIONNAIRES; TREATMENT OUTCOME;

EID: 25444503745     PISSN: 0195668X     EISSN: None     Source Type: Journal    
DOI: 10.1093/eurheartj/ehi170     Document Type: Article

References (18)

1. Del Sette M, Angeli S, Leandri M, Ferriero G, Bruzzone GL, Finocchi C, Gandolfo C. Migraine with aura and right-to-left shunt on transcranial Doppler: a case-control study. Cerebrovasc Dis 1998;8:327-330.
2. Sztajzel R, Genoud D, Roth S, Mermillod B, Le Floch-Rohr J. Patent foramen ovale, a possible cause of symptomatic migraine: a study of 74 patients with acute ischemic stroke. Cerebrovasc Dis 2002;13:102-106.
3. Anzola GP. Clinical impact of patent foramen ovale diagnosis with transcranial Doppler. Eur J Ultrasound 2002;16:11-20.
4. Wilmshurst P, Nightingale S. Relationship between migraine and cardiac and pulmonary right-to-left shunts. Clin Sci (Lond) 2001;100:215-220.
5. Wilmshurst PT, Nightingale S, Walsh KP, Morrison WL. Effect on migraine of closure of cardiac right-to-left shunts to prevent recurrence of decompression illness or stroke or for haemodynamic reasons. Lancet 2000;356:1648-1651.
6. Morandi E, Anzola GP, Angeli S, Melzi G, Onorato E. Transcatheter closure of patent foramen ovale: a new migraine treatment? J Interv Cardiol 2003;16:39-42.
7. Post MC, Thijs V, Herroelen L, Budts WI. Closure of a patent foramen ovale is associated with a decrease in prevalence of migraine. Neurology 2004;62:1439-1440.
8. Schwerzmann M, Wiher S, Nedeltchev K, Mattle HP, Wahl A, Seiler C, Meier B, Windecker S. Percutaneous closure of patent foramen ovale reduces the frequency of migraine attacks. Neurology 2004;62: 1399-1401.
9. Headache Classification Committee of the International Headache Society. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia 1988;8:1-96.
10. Goadsby PJ, Olesen J. Diagnosis and management of migraine. BMJ 1996;312:1279-1283.
11. Stewart WF, Shechter A, Rasmussen BK. Migraine prevalence. A review of population-based studies. Neurology 1994;44:S17-S23.
12. Lusic I. Population variation in migraine prevalence-the unsolved problem. Coll Antropol 2001;25:695-701.
13. Lipton RB, Stewart WF, Reed M, Diamond S. Migraine's impact today. Burden of illness, patterns of care. Postgrad Med 2001;109:38-40, 43-45.
14. Steiner TJ, Scher AI, Stewart WF, Kolodner K, Liberman J, Lipton RB. The prevalence and disability burden of adult migraine in England and their relationships to age, gender and ethnicity. Cephalalgia 2003;23:519-527.
15. Arquizan C, Coste J, Touboul PJ, Mas JL. Is patent foramen ovale a family trait? A transcranial Doppler sonographic study. Stroke 2001; 32:1563-1566.
16. Goadsby PJ, Lipton RB, Ferrari MD. Migraine-current understanding and treatment. N Engl J Med 2002;346:257-270.
17. Yankovsky AE, Kuritzky A. Transformation into daily migraine with aura following transcutaneous atrial septal defect closure. Headache 2003;43:496-498.
18. Gupta V. Closure of atrial septal defect and migraine. Headache 2004;44:291.